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volumes in treated volumes depended on
bladder fillings. CONCLUSIONS Implementation
of 3D treatment planning system in teletherapy
of cervical cancer helps to avoid a geographical
miss, to reduce both the treated volume and the
doses delivered to organs at risk.
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Purpose: evaluation 3-field(3F) and 4-field(4F)
planning techiniques for patients with localized
prostate cancer. Materials/methods: Five
patients with prostate cancer (T3NOMO) were
evaluated. CT images were obtained at 5mm
increments and were transferred to
CadPlan_planning_workstation. The planning
target volume (PTV) was detined as prostate
and seminal vesicles with 15mm margins
around c1inical target volume (CTV) except
prostate-rectum interface where 5mm margin
was applied. CTV was detined as prostate and
seminal vesicles.Following organs at risk (CAR)
were outlined: rectum, bladder, right temaral
head. Following 3F and 4F plans were
performed: 3F with angles (Odeg-120deg-
240deg; Odeg-90deg-270deg) and 4F (Odeg-
90deg-180deg-270deg). We also created two
versions ot treatment plans including ot energy;
6MV and 20MV for Clinac2300CD. Total dose
was 74Gy. Mean total doses ot thirty plans in
irradiated organs at risk (rectum, bladder and
righ temoral head) were compared. For PTV
mean and minimum dose were criteria tor
comparision ot treatment plans. Results: There
were no significant dose differenes between
evaluated plans ot treatment in PTV(0.05).
Secause mean dose in femoral head in each
treatment plan was below tolerance dose, main
dose-Iimiting organ was rectum and bladder.
Lowest mean dose 42.7 Gy in rectum was
achived by application ot 3F technique ot
20MV(Odeg-90deg-270deg). SIadder was also
spared with the same 3F technique of 20MV,
where mean dose was 45.2Gy. Conclusions:
This study showed that the "T" three-tield
technique (an anterior and two opposing lateral
tields) provided with 20 MV is optimal and
assures the lowest rectal dose.
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Srachytherapy is known and used procedure
in the treatment of tumours localised in eyes,
especially recommended when avoiding ot
enucleation accompany the long term cure.
Aim: The aim ot this paper was to compare
the doses delivered to the tumour and critical
tissues during the treatment of the group ot
patients treated with Ru-106 applicator.
Patients: Setween 1994 and 2000, 67
patients (dgn. melanoma malignum in eye)
underwent brachytherapy. At 51 patients the
tumour was localized in the back ot eye, at 15
equatorially and at one in the tront section ot the
eyeball. The median ot the patients' age was
56.3 years. The CCS type applicator was
applied for 56 patients, the COS for 7 and the
ROA tor 4 patients.
Method: Irradiation - Prescribed dose of 60
Gy was normalized to the top ot the tumour, it
decreased by 50%-10% per millimetre with the
distance trom applicator. The isotope producer
determined the dose-rate accuracy tor +/-30%.
This caused that therapeutic dose had to be
calculated taking account tor the minimai dose-
rate, while the doses in critical organs for
maximai dose-rate possible.
Analysis: Ali patients were divided into three
subgroups: 8 patients into 1sI , 19 into 2nd and 40
into 3rd • The inclusion criterion was size of
tumour: up to 3 mm of height (1 S1 group), 3-5
mm (2nd), and larger than 5 mm (3rd)
respectively.
Results: Table presents mean doses in the
tumour, selera and lens (calculated at it's
middle) tor each group ot patients.
Tumour Doses [Gy]
size
[mm] Tumour Selera lens
<3 102.9 162.4 137.6
3-5 186.2 463.5 396.2
>5 268.2 974.9 840.6
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